SPEAKER_04

So why don't we just put it on GitHub and let people learn from it?

So back when I was a grad student in the 80s, basic research as opposed to translational research –

was considered the height of intellectual desire, right?

Basic research and we're not here to make money.

We're here to discover things.

And that's important.

And nearly every major discovery and every major therapy in the world came from basic research.

But then, you know, there were limits to how much money you could give to basic research.

And then there was a desire at a certain point to say, hey, are you going to do anything about this?

You know, are you going to make it?

And so translational research became a push.

So this guy at Stanford by the name of Paul Berg, who won the Nobel Prize for recombinant DNA way back in the day,

And Paul came up with this concept, bench to bedside, meaning that we don't have to be either or.

We can be part of an arc.

And Stanford wanted to be an enable within the medical school, both the basic research, which we were great at,

as well as bringing it directly to the patients as well.

So to link clinicians and the desires of clinicians with the basic researchers.

I mean, most scientists would be happy just to study anything.

You know, just point me at something and I'll be happy if I can get interested in it.

So, and we're no more happy than when somebody recognizes the value of what we do.